Radioimmunotherapy as a novel treatment regimen: 125I-labeled monoclonal antibody 425 in the treatment of high-grade brain gliomas-Reference-Cited by-同舟云学术

Radioimmunotherapy as a novel treatment regimen: 125I-labeled monoclonal antibody 425 in the treatment of high-grade brain gliomas

Published:2004-03 Issue:3 Volume:58 Page:972-975
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Quang Tony S.,Brady Luther W.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference34 articles.

1. Cancer statistics, 2002;Jemal;Cancer J Clin,2002

2. The prognostic impact of prior low-grade histology in patients with anaplastic gliomas;Dropcho;Neurology,1996

3. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme;Simpson;Int J Radiat Oncol Biol Phys,1993

4. Long term survival in treated anaplastic astrocytomas;Fischbach;Am J Clin Oncol (CCT),1991

5. Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor;Brady;Int J Radiat Oncol Biol Phys,1991

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA Repair Inhibitors: Potential Targets and Partners for Targeted Radionuclide Therapy;Pharmaceutics;2023-07-11

2. Nuclear medicine therapy of CNS tumors;Nuclear Medicine and Molecular Imaging;2022

3. Radioimmunotherapy of glioblastoma multiforme - Current status and future prospects;Critical Reviews in Oncology/Hematology;2021-07

4. Combination radionuclide therapy: A new paradigm;Nuclear Medicine and Biology;2021-07

5. Targeted Radionuclide Therapy Using Auger Electron Emitters: The Quest for the Right Vector and the Right Radionuclide;Pharmaceutics;2021-06-29